Exclusive: Microsoft, Sam Altman back a new AI biotech upstart

Jason Mast

Editor

Most artificial intelligence biotechs start with a computer scientist or two and an algorithm. Jen Nwankwo started from the other side of the spectrum. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Exclusive: Microsoft, Sam Altman back a new AI biotech upstart

Jason Mast

Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Ex­clu­sive: Mi­crosoft, Sam Alt­man back a new AI biotech up­start

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Exclusive: Microsoft, Sam Altman back a new AI biotech upstart